BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

DiaMedica Inc. 

B-1250 Waverley Street

Winnipeg  Manitoba  R3T 6C6  Canada
Phone: 204-487-3806 Fax: 204-453-3745


SEARCH JOBS




Industry
Biotechnology






 Company News
Struggling DiaMedica Inc. Cuts Jobs; CFO Out 12/9/2014 9:59:11 PM
DiaMedica Inc. Announces Top-Line Results Of Phase 2a Clinical Trial Of DM199 For Type 2 Diabetes 11/17/2014 6:47:26 AM
DiaMedica Inc. Moves HQ to Twin Cities; Plans to Hire 10/25/2012 8:09:07 AM
DiaMedica Inc. Announces Influenza Program and Enters Into an Evaluation Agreement With the U.S. National Institute of Allergy And Infectious Diseases (NIAID) for Influenza Infections 1/26/2011 10:41:33 AM
DiaMedica Inc. Announces New Data With Its Novel Monoclonal Antibody Program 1/18/2011 9:57:56 AM
DiaMedica Inc. Receives $2.7 Million Through Accelerated Warrant Exercise 12/28/2010 12:14:49 PM
DiaMedica Inc. Accelerates Warrant Expiry Date 11/22/2010 12:32:40 PM
DiaMedica Inc. Announces Research Collaboration with The Sanford Project, a Leading Type 1 Diabetes Research Center 11/9/2010 11:12:28 AM
DiaMedica Inc. Announces Issuance of Stock Options 11/5/2010 8:21:11 AM
DiaMedica Inc.'s DM-199 Validated by Significantly Increasing Insulin Sensitivity by 122% 10/27/2010 9:44:10 AM
123456